alpha-msh - CISMeF

Preferred Label : alpha-msh;

MeSH definition : A 13-amino acid peptide derived from proteolytic cleavage of ADRENOCORTICOTROPIC HORMONE, the N-terminal segment of ACTH. ACTH (1-13) is amidated at the C-terminal to form ACTH (1-13)NH2 which in turn is acetylated to form alpha-MSH in the secretory granules. Alpha-MSH stimulates the synthesis and distribution of MELANIN in MELANOCYTES in mammals and MELANOPHORES in lower vertebrates.;

MeSH synonym : acetylated acth (1-13)nh2; hormone, alpha-melanocyte-stimulating; msh, alpha; alpha melanotropin; alpha-melanocyte-stimulating hormone; alpha melanocyte stimulating hormone; alpha-Melanotropin; alpha MSH; alpha Intermedin; Intermedin, alpha;

MeSH hyponym : ACTH (1-13); ACTH (1-13)NH2; (Desacetyl)alpha-MSH; DE-alpha-MSH; MSH, (Desacetyl)alpha-; Des-Acetyl MSH; MSH, Des-Acetyl; Desacetyl alpha-MSH; Desacetyl alpha MSH; alpha-MSH, Desacetyl; Desacetyl alpha-Melanocyte-Stimulating Hormone; Desacetyl alpha Melanocyte Stimulating Hormone; Hormone, Desacetyl alpha-Melanocyte-Stimulating; alpha-Melanocyte-Stimulating Hormone, Desacetyl; (Des-Acetyl)-alpha-MSH; Adrenocorticotropin (1-13)NH2; ACTH(1-13);

MeSH CAS label : alpha-melanotropin;

Registry Number MeSH : 581-05-5;

Wikipedia link : https://en.wikipedia.org/wiki/Alpha melanocyte stimulating hormone;

Is substance : O;

Details

Origin ID

D000521;

UMLS CUI

C0002302;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Alpha melanocyte stimulating hormone [LOINC component]
- Alpha-melanocyte stimulating hormone (substance) [SNOMED CT concept]
- Melanotropin Alpha [NCIt concept]
- alpha-melanocyte stimulating hormone [SNOMED Notion]
Indexing information
- 153N-6 peptide [MeSH Supplementary Concept]
- MSH receptor [MeSH Supplementary Concept]
Pharmacological action(s)
- hormones [MeSH Descriptor]
Record concept(s)
- ACTH (1-13) [MeSH concept]
- ACTH (1-13)NH2 [MeSH concept]
- alpha-MSH [MeSH concept]
Related MeSH Supplementary Concept(s)
- (111)indium-alpha-MSH (3-10), DOTA-beta-Ala(3)-Nle(4)-Asp(5)-Phe(7)-Lys(10)- [MeSH Supplementary Concept]
- 1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (Cys(3,4,10),D-Phe(7))alpha-MSH(3-13) [MeSH Supplementary Concept]
- 1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO-acetyl(Cys(3,4,10),Phe(7),Arg(7))alpha-MSH(3-13)) [MeSH Supplementary Concept]
- 64Cu-DOTA-NAPamide [MeSH Supplementary Concept]
- 68Ga-1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO-acetyl(Cys(3,4,10),Phe(7),Arg(7))aplha-MSH(3-13)) [MeSH Supplementary Concept]
- ACTH (6-9) [MeSH Supplementary Concept]
- AP 214 [MeSH Supplementary Concept]
- MC4-NN1-0182 [MeSH Supplementary Concept]
- MSH(4-9)NH2, Ac-(Nle(4)-Phe(7))alpha- [MeSH Supplementary Concept]
- MSH, (2-Phe-4-Nle)alpha- [MeSH Supplementary Concept]
- MSH, (Ala-4'-azido-3',5'-ditritio-Phe-nor-Val)alpha- [MeSH Supplementary Concept]
- MSH, 12-Bct-1-N(alpha)-dodecanoyl-Ser-4-Nle-7-Phe-alpha- [MeSH Supplementary Concept]
- MSH, 13-(4-azido-Phe)alpha- [MeSH Supplementary Concept]
- MSH, 2-(3,5-diiodo-Tyr)alpha- [MeSH Supplementary Concept]
- MSH, 2-Tyr-alpha- [MeSH Supplementary Concept]
- MSH, 4-Nle-7-Phe-alpha- [MeSH Supplementary Concept]
- MSH, 4-Nle-alpha- [MeSH Supplementary Concept]
- MSH, 4-half-Cys-10-half-Cys-alpha- [MeSH Supplementary Concept]
- MSH, N(alpha)-Bct-1-Ser-4-Nle-7-Phe-alpha- [MeSH Supplementary Concept]
- MSH, N(alpha)-chlorotriazinylaminofluorescein-1-Ser-4-Nle-7-Phe-alpha- [MeSH Supplementary Concept]
- N,O-diacetyl-Ser(1)-alpha-MSH [MeSH Supplementary Concept]
- N-acetyl-MSH [MeSH Supplementary Concept]
- acetyl-norleucyl(4)-(aspartyl(5)-histidyl(6)-phenylalanyl(7)-arginyl(8)-tryptophyl(9)-lysyl(10))cyclo-alpha-MSH(4-10)amide [MeSH Supplementary Concept]
- acetyl-norleucyl-aspartyl-histidyl-phenylalanyl-arginyl-beta-methyltryptophyl-lysinamide, cyclic (2-7)-peptide [MeSH Supplementary Concept]
- acetylnorleucyl-glutamyl-histidyl-phenylalanyl-arginyl-tryptophyl-glycyl-lysinamide [MeSH Supplementary Concept]
- afamelanotide [MeSH Supplementary Concept]
- alpha-MSH (1-13), Val(13)- [MeSH Supplementary Concept]
- alpha-MSH (1-13)amide, (Nle(4),Phe(p-I)7)- [MeSH Supplementary Concept]
- alpha-MSH (4-10)NH2, Ac-Nle(4)-Glu(gamma-4'-hydroxyanilide)(5)-Phe(7)- [MeSH Supplementary Concept]
- alpha-MSH (4-10)amide, Ac-Nle(4)-cyclo(Asp(5)-Phe(7)-Lys(10))- [MeSH Supplementary Concept]
- alpha-MSH (4-11), acetyl0Nle(4)-Asp(5)-Phe(7)- [MeSH Supplementary Concept]
- alpha-MSH (4-11)NH2, Ac-Nle(4)-Orn(5)-Glu(8)- [MeSH Supplementary Concept]
- alpha-MSH (6-11)-amide, Trp(7)-Ala(8)-Phe(10)- [MeSH Supplementary Concept]
- alpha-MSH (6-11)amide, D-tryptophyl(7)-D-phenylalanyl(10)- [MeSH Supplementary Concept]
- alpha-MSH (8-13), Val(13)- [MeSH Supplementary Concept]
- alpha-MSH(3-13), N-(2-aminoethyl)-1,2-diaminocyclohexane-N,N',N''-pentaacetic acid-Re(Cys(3,4,10))-Phe(7)-Arg(11)- [MeSH Supplementary Concept]
- alpha-MSH(4-11)NH2, Ac-Nl4(4)-Orn(5)-Phe(7)-Glu(8)- [MeSH Supplementary Concept]
- alpha-MSH, (125)I-Tyr(2)-Nle(4)-Phe(7)- [MeSH Supplementary Concept]
- alpha-MSH, Ac-cyclo(Cys(4)-Cys(10))- [MeSH Supplementary Concept]
- alpha-MSH, Nle(4)-Phe(7)-(NAPS)Trp(9)- [MeSH Supplementary Concept]
- alpha-MSH-melphalan conjugate [MeSH Supplementary Concept]
- alpha-melanotropin hydrazide [MeSH Supplementary Concept]
- bremelanotide [MeSH Supplementary Concept]
- diphtheria toxin-related-alpha-melanocyte-stimulating hormone fusion toxin [MeSH Supplementary Concept]
- enkorten [MeSH Supplementary Concept]
- gadolinium alpha-MSH (4-11), Nle(4)-Asp(5)-Phe(7)-epsilon(DOTA)Lys(11)- [MeSH Supplementary Concept]
- melanotan-II [MeSH Supplementary Concept]
- setmelanotide [MeSH Supplementary Concept]
- technetium 99m HYNIC-Ahx-cycMSH(4-13) [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Hormone [UMLS semantic type]
UMLS correspondences (same concept)
- Alpha melanocyte stimulating hormone [LOINC component]
- Alpha-melanocyte stimulating hormone (substance) [SNOMED CT concept]
- alpha-melanocyte stimulating hormone [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients